Panel Attempts Thrombosis Prevention In Taxus Labeling, Clears Seven Sizes

Labeling for Boston Scientific'sTaxus paclitaxel-eluting stent should highlight the need for patients to take an anti-platelet and aspirin regimen for the first six months to prevent blood clots, FDA's Circulatory System Devices Panel recommends